Tradename | Company | Number | Date | Products |
---|---|---|---|---|
DURACLON | Mylan | N-020615 RX | 1996-10-02 | 1 products, RLD |
ONYDA XR | Tris Pharma | N-217645 RX | 2024-05-24 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
COMBIPRES | Boehringer Ingelheim | N-017503 DISCN | 1982-01-01 | 3 products, RLD |
Brand Name | Status | Last Update |
---|---|---|
catapres | New Drug Application | 2010-12-10 |
catapres-tts-1 catapres-tts-2 catapres-tts-3 | New Drug Application | 2024-10-11 |
clondine | ANDA | 2010-03-15 |
clonidine | ANDA | 2024-02-05 |
clonidine hci | ANDA | 2022-12-09 |
clonidine hydrochloride | ANDA | 2025-03-27 |
clonidine hydrochloride tablets | ANDA | 2009-09-18 |
clonidine transdermal system | ANDA | 2023-11-28 |
clonidine transdermal system usp, 0.1 mg/day clonidine transdermal system usp, 0.2 mg/day clonidine transdermal system usp, 0.3 mg/day | New Drug Application | 2024-10-14 |
duraclon | New Drug Application | 2021-03-17 |
Code | Description |
---|---|
J0735 | Injection, clonidine hydrochloride, 1 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hyperkinesis | D006948 | — | — | — | — | — | 1 | — | 1 |
Attention deficit disorder with hyperactivity | D001289 | EFO_0003888 | F90 | — | — | — | 1 | — | 1 |
Drug common name | Clonidine |
INN | clonidine |
Description | Clonidine (imino form) is a clonidine. It is a tautomer of a clonidine (amino form). |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | Clc1cccc(Cl)c1NC1=NCCN1 |
PDB | — |
CAS-ID | 4205-90-7 |
RxCUI | — |
ChEMBL ID | CHEMBL134 |
ChEBI ID | 3757 |
PubChem CID | 2803 |
DrugBank | DB00575 |
UNII ID | MN3L5RMN02 (ChemIDplus, GSRS) |